BIOTECH, TECHNOLOGY
Matthew Scholz
CEO,
Oisin Biotechnologies
- Chief Executive Officer & Co-founder of Oisin Biotechnologies
Follow
About Matthew
Matthew Scholz is chief executive officer and co-founder of Oisin Biotechnologies and its oncology-focused spin-out OncoSenX, two biotech firms commercializing a breakthrough platform technology for killing unwanted cells based on their genetics. A serial entrepreneur with a background in computer security, immunology, and gene therapy. He was previously the founder and CEO of Immusoft, a biotech firm developing a technology that turns patients' B cells into miniature drug factories. Mr. Scholz speaks and presents regularly to university, association, and scientific audiences, including those at his alma mater, the University of Washington. He served for several years as a mentor to recipients of the Thiel Fellowship, a program that awarded grants to some of the world's brightest scientific minds under age 20.
Matthew's Videos
The essence of life is information, chemicals are the substrate. Without the information contained in our DNA, we'd be a few dollars' worth of chemicals lying on the ground. With this information, our bodies turn food into a human being. In the past few years, science and medicine have reached the point where we can treat life-threatening diseases by modifying the information in patients' DNA. These advances will forever change the way we look at medicine, redefining what we think is possible. In the near future we will see treatments that treat aging itself as a disease, vastly improving both the healthspan and lifespan of mankind.
Matthew Scholz
HEALTHCARE
26:49
This panel features two CEOs whose companies are at the forefront of innovation in biotech. Brief company presentations will be followed by a discussion of how technology and knowledge is being incorporated into biotech business models with specific examples from both companies. The panel will conclude with a look at the future of knowledge and its continued impact on powering the biotech revolution.
Matthew Scholz
TECHNOLOGY
49:55